Premium
Loss of PTEN is associated with progression to androgen independence
Author(s) -
Bertram Jerod,
Peacock James W.,
Fazli Ladan,
Mui Alice L.F.,
Chung Stephen W.,
Cox Michael E.,
Monia Brett,
Gleave Martin E.,
Ong Christopher J.
Publication year - 2006
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/pros.20411
Subject(s) - pten , prostate cancer , androgen , prostate , downregulation and upregulation , tumor progression , medicine , endocrinology , cancer , cancer research , hormone , biology , apoptosis , pi3k/akt/mtor pathway , gene , biochemistry
BACKGROUND Progression to a lethal androgen‐independent (AI) stage of advanced prostate cancer is a critical clinical obstacle limiting patient survival. PTEN inactivation is frequently observed in advanced prostate cancer and correlates with a poor prognosis. However, the functional significance of PTEN inactivation in AI progression has not been demonstrated. METHODS PTEN expression was examined in benign, hormone naïve and AI human prostate cancer specimens, and in recurrent AI Shionogi tumors. The effect of antisense oligonucleotide (ASO)‐mediated PTEN downregulation in AI progression of the Shionogi tumor model was determined. RESULTS Significantly reduced PTEN expression was observed in AI versus benign and hormone naïve prostate tumors. Seven of 14 AI Shionogi tumors exhibited marked downregulation or complete loss of PTEN. ASO‐mediated PTEN inhibition reduced androgen‐withdrawal induced regression of Shionogi tumors and accelerated AI progression. CONCLUSIONS These data suggest that PTEN inactivation may play a role in progression to androgen independence. Prostate 66: 895–902, 2006. © 2006 Wiley‐Liss, Inc.